NCT02405520 2022-05-24Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent VaccineXiamen UniversityPhase 1 Completed145 enrolled
NCT03813940 2021-04-08Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)Xiamen UniversityPhase 1 Completed24 enrolled